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Neonatal thymectomy  depresses the immune response of conventional and germfree 
mice to sheep erythrocytes (1, 2). The capacity to produce 19S hemolysin-forming 
cells develops later after thymectomy at birth and the number attained at the height 
of the response is approximately 1 logt0 lower than in normal mice (1, 3). Thoracic 
duct cell output studies indicate that the number of recirculating small lymphocytes 
may be as low as 1% of normal (3). In addition, the thoracic duct cell population of 
neonatally thymectomized mice is markedly deficient in cells capable of transferring 
adoptively, to heavily irradiated mice, immunological responsiveness to sheep erythro- 
cytes (3). 
Studies with  tritiated  thymidine-labeUng  techniques  (4,  5)  indicate that  some 
lymphocytes  may leave the thymus and eventually appear in those areas of the lymph 
nodes and spleen known to be the site of traffic of recirculating small lymphocytes (6). 
The evidence obtained from the labeling and thymectomy experiments support the 
concept that the thymus may be the original source of some of these recirculating cells 
(7). Further support for this would be obtained if it could be shown that, under certain 
experimental conditions,  thymus lymphocytes behaved and  functioned exactly as 
thoracic duct lymphocytes. 
The  immunological  responsiveness  of  neonatally  thymectomized mice  to 
sheep erythrocytes can be restored to normal by an injection of thoracic duct 
cells from normal donors (3). The exact relationship between the injected cells 
and the resulting hemolysin-forming cells is, however, unknowIl. The present 
series of papers deals with the capacity of thymus or thoracic duct cells to trans- 
fer responsiveness to sheep erythrocytes in mice crippled immunologically as a 
result of thymectomy, irradiation, or treatment with anti-lymphocyte serum. 
The relationship between the transferred cells and the precursors of the anti- 
body-forming cells has been examined by the use of anti-H2 sera, anti-aUotype 
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sera,  and  chromosome  markers.  The  first  paper  in  the  series  deals  with  the 
identity of the hemolysin-forming cells produced in response  to sheep erythro- 
cytes in neonatally thymectomized mice reconstituted with thymus or thoracic 
duct cells. A  preliminary report of this work has been published  (8). 
Materials  and  Methods 
Animals.--Male and female mice of the highly inbred strains CBA (originally obtained from 
Harwell, Didcot, Berkshire, England), C57BL  (originally obtained by Dr. R. Bradley of the 
University of Melbourne from Dr. L. W. Law of the National Institutes of Health, Bethesda, 
Md.), and the (CBA X  C57BL)F1  hybrids were used. The mice were raised and maintained 
at the Hall Institute and were fed Barastac cubes with an occasional green feed supplement of 
cabbage and water ad libiSum. Neonatally thymectomized mice were reared on foster mothers 
of a randomly bred Hall Institute strain with a  view to minimizing losses from cannibalism 
in the immediate postoperative period. Oxytetracycline,  t at a dose level of 100 mg per liter, 
was added to the drinking water each day. 
Preparation of Cell Suspensions.--Thymus  lobes were removed from 6- to 8-wk-old mice, 
care being taken to avoid fascial tags which might contain mediastinal lymph nodes. The lobes 
were teased with fine forceps through an 80 mesh stainless steel sieve in cold medium 1997 
Further disruption was achieved by gentle aspiration using a Pasteur pipette. The suspension 
of single cells was washed three times in medium 199 and the cells were finally resuspended 
in cold Dulbecco's phosphate-buffered saline. They were counted in a hemocytometer and the 
volume adjusted so that the number of cells required for injection was contained in 0.2-0.5 ml, 
depending on the experiment. 
Bone marrow cells were expressed from the femurs and tibiae by means of a  syringe and 
attached needle containing cold medium  199. The marrow pings were gently disrupted  by 
aspiration through a  25 gauge needle. The suspension  of single cells was washed once, resus- 
pended in cold phosphate-buffered saline, counted, and  the volume adjusted so that the re- 
quired dose could be injected in a  suitable volume. 
Thoracic  duct  lymphocytes were obtained  as  described  below and  the  cell suspension 
washed and resuspended as mentioned above for marrow cells. 
Sheep erythrocytes were obtained from a single animal assigned to this work. The jugular 
vein was punctured at weekly intervals, the blood collected and stored in Alsevers' solution 
for 1 wk prior to use.  When required, the cells were washed three times in saline and finally 
resuspended to an appropriate volume for injection. The number of cells used for immuniza- 
tion purposes was 1-2 X  l0  s (0.1 ml of a 20% suspension). 
Yeast cells were prepared by dissociating commercial baker's yeast into a single cell sus- 
pension. 
Irradiation of Cell Suspensions.--Thoracic  duct cells and thymus cells were X-irradiated in 
circular plastic dishes (30 mm diameter) with 1000 rads at a  focal distance of 50 cm and a 
dose rate of 120 rads per minute using an X-ray machine operating under conditions of 250 kv, 
15 ma, andan HVL (half-value layer) of 1 mm Cu. The eells were suspended in ice cold Eisen's 
balanced salt solution containing 10% fetal calf serum in a volume which completely filled the 
dish. 
Thymus Extracts.--Cell-free  saline thymus extracts were prepared from the thymuses of 
6-wk-old mice according to the method of Metcalf (9).  Each recipient mouse received the 
equivalent of one thymus lobe (approximately los cells)  by intraperitoneal  injection. 
Terramycin,  Pfizer Pry.  Ltd.,  Sydney,  Australia. 
t Tissue culture medium 199 with 100 t~g streptomycin and 100 units penicillin per milliliter 
was obtained from Commonwealth Serum Laboratories, Melbourne, Australia. ~'.  F.  A,  P.  MILLER  AND  G.  ~F.  MITCHELL  8O3 
Inje~tions.--All  cell suspensions to be injected were given into the tail vein, unless other- 
wise stated. In the case of thymus cells to be given in doses exceeding 10 million per mouse, 
it was found absolutely essential to spread the injection over 1-2 rain and give a large volume 
(0.4-0.5  ml) to prevent death from emboli. Mice did not have to be heparinized provided the 
injection was given slowly. 
Op~atire ProceJure~.--Thymectomy  or sham operation was performed in newborn mice, 
less than 36 hr old, according to the method of Miller (10).  Whenever thymectomized mice 
were killed, the mediastinum was examined macroscopically and, in some cases,  microscop- 
ically, to check for the presence of thymus remnants.  Only very few mice were found with 
such remnants and they were discarded from the experiments. 
The technique used to establish a  thoracic duct fistula was glrnilar  to that described by 
Boak and Woodruff (11). The only modification was the method of inserting the Boak thoracic 
polythene cannula, s Instead of stabbing the thoracic duct with the pointed end of the cannula, 
a  small sharp  pointed jeweller's forceps was used to pierce the left lateral wall of the duct. 
If ventral tension was maintained on the aorta while puncturing the duct, air was drawn in 
and the chylous lymph displaced. This displacement clearly defined the position of the hole 
and the width of the duct. The bevelled end of the caunula could then be slipped into the 
duct and the site of insertion sealed with a drop of the monomeric tissue adhesive, isobutyl-2- 
cyanoacrylate.' This manipulation reduced the risk of lacerating the duct or of penetrating 
the right lateral wall which lies adjacent to the vena cava. 15-30 rain prior to cannulation the 
mice were given 0.4 ml cream by intraesephageal instillation. The most s&tisfactory  anesthetic 
agent was found to be avertin  6 and was given intraperitonealiy as a 2% solution in 10% alcohol 
in doses of 0.1 mi/10 g body weight. The short duration of surgical anesthesia and  the rapid 
return of muscular activity markedly increased the rate of lymph flow which assisted in the 
expulsion of clots from the caunula. During the collection of lymph, the mice were restrained 
in modified Boliman cages (12) and the lymph allowed to drain into siliconized glass tubes 
kept in ice water in vacuum flasks and contn~nlng  10% normal mouse serum or fetal calf 
serum in Dulbecco's phosphate-buffered saline and  50-100 IU of preservative-free heparin  6 
per milliliter. A fine horse hair was passed up and down the cannula at regular intervals to 
clear lymph clots. 
Hemolytic. Plaque-Forming Cell Assays.--Spleen  cell suspensions for assays were prepared 
in a manner similar to that described above, washed once, and diluted to an appropriate vol- 
tune in medium 199 so that 0.1 ml contained an estimated number of 100-500 plaque-forming 
cells. The actual number of hemolysin-forming cells was determined on duplicate agar plates 
according to the method described by Jerne et al.  (13). 
Preparation of Anti-H2 Isoantisera.--Isoantisera  were prepared  by repeatedly injecting, 
at not less than 2owk-intervals,  6-wk-old CBA mice and C57BL mice with 20-100 million cells 
from pooled thymus, spleen, and mesenteric lymph nodes of adult  C57BL and  CBA mice, 
respectively. All mice received C57BL or CBA aliogeneic skin grafts between the 2nd and 3rd 
injection of lymphoid cells.  The skin grafting technique used was that  of Billingham and 
Medawar (14). The mice were bled 7-10 days after the last of three to six injections, the sera 
separated, inactivated at 56°C for 30 rain, and stored in small aliquots at  --20°C until re- 
quired. Normal sera were obtained from CBA and C57BL mice of the same age as that of the 
mice used for the preparation of the isoantisera. 
Incubation of Hemolysin-Forming Cells witk Isoantisera.--Spleen  cells were suspended  in 
Eisen's balanced salt solution containing 10% fetal calf serum and 0.15-mi aliquots of approxi- 
3 Portex, Portland Plastics Ltd., Hythe, Kent, England. 
4 Ethicon Inc., Somerville, N. J. 
Avertin with amylene hydrate, Winthrop Laboratories, N. Y. 
s Heparin, B. P. without preservatives, Evans Medical Ltd., Liverpool, England. 804  CELL TO  CELL INTERACTION IN IMMUNE RESPONSE. I 
mately 1-2 million ceils or 100--1000 plaque-forming ceils were incubated at 37°C for 30 rain 
with 0.05 ml undiluted anti-C57BL serum, anti-CBA serum, normal C57BL serum, or normal 
CBA serum,  and 0.05 ml undiluted guinea pig serum.  The cells were washed  once and re- 
suspended to a volume of approximately  0.2 ml. This entire amount was plated onto two agar 
plates and developed according to the usual procedure. A similar technique for the inhibition 
of plaque-forming cells by isoantisera has recently been described (15). 
Induction of Immunological Tolerance to Sheep Erythrocytes.---8-wk-old CBA  mice  were 
made tolerant to sheep erythrocytes according  to the method of Dietrich and Dukor (16). 
They received one intraperitoncal injection of 0.5 mi packed sheep red cells and 24 hr later a 
subcutaneous  injection of cyclophosphamide 7 in phosphate buffer in a dose of 1 rag/10 g body 
weight. Control mice were injected only with cyclophosphamide. Some mice from both groups 
were tested for specific immunological tolerance by challenging them 23-26 days later with 
either sheep or horse erythrocytes given intravenously (0.1 ml of a 20% suspension). At the 
same time, other mice had their thoracic duct catmnlated and the lymphoeytes collected for 
12-16 hr. These donor mice were also tested individually  for specific tolerance after closure of 
the fistula and removal from the restraining apparatus. Plaque-forming  cell assays were per- 
formed on spleen cell suspensions 4--5 days after challenge.  Since horse erythrocytes do not 
spread evenly in agar, the agar-frce system described by Cunningham  and Szenberg (17) was 
used to assay the number of plaque-forming cells in this case. 
Statistical Anagys/s.--The standard errors of  the  means  were  calculated and P  values 
determined by Student's t test. 
RESULTS 
Transfer of Syngeneic  Thymus or Thoracic Duct Calls.--3- to 5-wk-old neo- 
natally thymectomized CBA mice were injected intravenously with l0  s SRBC  s 
and  either  10  or  50  million syngeneic  thymus  cells or  10  million syngeneic 
thoracic duct ceils. Some neonatally thymectomized and sham-operated litter- 
mates were given SRBC  alone. The PFC  response per spleen, in mice of the 
various groups, was measured at 2,4,5,7, and 10 days. As shown in Fig. 1, sham- 
thymectomized mice produced  a  peak response of 32,000  PFC  whereas neo- 
natally thymectomized mice could produce only 2300 PFC. 10 million thymus 
cells and  10  million thoracic duct  cells increased  the  peak  response  by  ap- 
proximately 20,000 PFC. 50 million thymus cells increased the number of PFC 
to levels obtained in sham-operated controls. In all groups, the peak PFC  re- 
sponse occurred 4-5 days after challenge. 
A  statistical analysis of the 4-5  day PFC  responses of mice of the various 
groups is given in Table I. Also included in this table is the background number 
of PFC  in mice not  injected with  SRBC.  It can  be seen  that  the increased 
response of thymectomized mice given SRBC and 10 million thymus or thoracic 
duct ceils or 50 million thymus cells is statistically significant. One and a  half 
million  thoracic  duct  cells,  however,  produced  no  significant  increase.  The 
7  Endoxan Asta, Charles McDonald, Caringbah, Australia. 
s The following abbreviations are used: SRBC, sheep erythrocytes; HRBC, horse erythro- 
cytes; PFC, hemolysin plaque-forming cells; NS, not significant; and sE, standard error. j.  ~.  A.  P.  MILLER  AND  G.  1L  MITCHELL  805 
background number of PFC was similar in thymectomi~ed and sham-operated 
mice as previously reported (18), and was slightly increased in thymectomized 
mice injected with 10 million thymus or thoracic duct cells. 
4qOO0- 
Z 
ILl 
~1  3qooo-  fl. 
I/) 
r,' 
U.I  D. 
I/) 
J, 
,,,  20,O00- 
L) 
o 
i 
w  IO,  OO0. 
0 
J 
-  2  3  4  5  0  7  8  9  IO 
DAYS  AFTER  INJECTION  OF  SRBC 
FIO. 1. PFC produced in the spleens of neonatally  thymectomized  CBA mice at various 
times after injection of SRBC and syngeneic thymus or thoracic duct cells.  [] ........  D, sham- 
operated controls given SRBC only; O~O,  neonatally thymectomized mice given SRBC 
only;  •  -  O,  neonatally  thymectomized  mice given  10  million CBA thymus  cells and 
SRBC; /x  /% neonatally thymectomlzed mice given 50 million CBA thymus cells and 
SRBC; •  •,  neonatally thymectomized mice given 10 million thoracic duct cells and 
SRBC. The number of mice per point was 3-20 with an average of 7. 
During the course of these experiments,  the spleens of neonatally thymec- 
tomized mice were found to be consistently enlarged and, at 4-5 days following 
an injection of SRBC and thoracic duct or thymus cells, contained up to 300 
million nucleated cells. The spleen weights and number of nucleated cells per 
spleen  were  determined on a  total of 31  uninjected thymectomiTed,  sham- 
operated, and normal 3- to 4-wk-old mice. The size of the spleen in thymec- 
tomized mice was approximately twice that in sham-operated or normal mice 806  CELL  TO  CELL  INTERACTION  IN  ~  RESPONSE.  I 
(Table II).  Splenic  enlargement  in  thymectomized mice has been  previously 
reported  and  ascribed  to hyperplasia  of the  myeloid  and  reticuloendothelial 
systems (19, 20). 
TABLE I 
PFC  Produced  in  the  Spleens  of Neon;tally  Thymectomlzed CBA  Mice  after  Injeaion  of 
SRBC  and  Syngenci¢  Thymus or  Thoracic Duct  Cells 
Group 
1. Thymectomized 
2.  Thymectomized 
3.  Thymectomized 
4. Thymectomized 
5. Thymecto~ 
6.  Thymectomized 
7. Thymectomized 
8. Thymectomized 
9.  Sham-operated 
[0.  Sham-operated 
Cells inoculated 
SRBC 
10 X  106  thymus 
SRBC 
50 X  10  °  thymus 
SRBC 
•  1.5 X  106  thoracic 
ceils +  SRBC 
10 ×  10  s  thoracic 
ceils +  SRBC 
cells + 
cells + 
duct 
duct 
10 X 106  thymus ceils only 
10 X  10  e thoracic  duct cells 
only 
Nil 
Nil 
SRBC 
No. of 
mice 
16 
2O 
23 
5 
12 
6 
4 
5 
9 
36 
Average PFC 
per  spleen  at  4-5 
days (±sz) 
2,356 4- 537 
19,160 4- 3,840 
38,855 4- 7,448 
3,510 4- 1,040 
20,254 4- 3,646 
241 4- 55 
323 4- 87 
106 4- 24 
123 4- 29 
32,17;' 4- 3,550 
P 
values (cf. 
group 1) 
<0.01 
<0.01 
N.S. 
<0.01 
<0.01 
TABLE II 
Sple.o~ Siz~ of Ne~aatally  Thyraextomiz~d and I~aa  CBA  Mice 
Mice 
Neonatally thymectomized 
Sham-thymectomized and 
unoperated 
Spleen cell  No. 
No. of 
mice 
17 
14 
Average No. of 
nucleated cells per 
spleen (-4-sz) 
X  10  -° 
148.0 4- 12.2 
78.6 4- 10.2 
No.  of 
mice 
7 
5 
Spleen weight 
Average body 
weight (-l-SZ) 
g 
8.54-O.7 
8.64-O.6 
Average  weight of 
spleen  per I0  g 
body welght  (:hsE) 
mg 
122,7 -4- 9.7 
53,8 -4- 2.1 
The  neonataUy  thymectomized mice used  in  our experiments  haA not yet 
shown any of the outward signs of wasting disease. In Fig. 2 are shown plots of 
the cumulative percentage mortality for neonatally thymectomized CBA mice 
which were either  uninjected  or which received  10 million syngeneic thoracic 
duct cells or 50 million syngeneic thymus cells at 3-4 wk of age. Deaths were 
first  recorded  at  6  wk  of age  and  at  12 wk,  14  out of  15  (93%)  uninjected J.  F. A. P. MILLER AND  G. F. MITCHELL  807 
thymectomized  mice had died in contrast to only 4 out of 12 (33 %) mice in the 
group receiving thoracic duct cells and 8 out of 14 (57 %) mice that were given 
thymus cells. 10 million thoracic duct cells thus prolonged survival of many 
thymectomized  mice but five times as many thymus cells protected fewer mice. 
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FIG.  2.  Cumulative percentage  mortality of neonataIly  thymectomlzed mice not given 
lymphoid ceils (  ), or injected at 3--4 wk of age with 50 million syngeneic thymus cells 
(---), or I0 million syngeneic thoracic duct cells ( .... ). 
Transfer of Allogeneic Thymus or Thoracic Duct Cells.--The PFC responses of 
neonatally thymectomized CBA mice given SRBC and 10 million  (CBA  X 
C57BL)F1 thymus or thoracic duct cells are shown in Fig. 3. It can be seen that 
both these inocula were effective in elevating the response  of their thymec- 
tomized hosts but, in the case of Fx thoracic duct ceils, the PFC response was 
prolonged with a peak at 7 days. 
When C57BL thymus or thoracic duct cells were given to neonatally thy- 
mectomized  CBA mice,  the condition of the recipients  progressively  deteri- 
orated after 5-6 days due to the development of a graft versus host reaction. 808  CELL  TO  CELL  INTERACTION  IN"  TM'MUNE  RESPONSE.  I 
Hence the PFC response of these mice was measured not later than 4-5 days 
after challenge with  SRBC and  inoculation of C57BL cells.  The results  are 
given in Table IH and compared with the 4-5 day responses of mice receiving 
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FIo. 3. PFC produced in the spleens of neonatally thymectomized CBA mice at various 
timesafter injection of SRBC  and (CBA X C57BL)F~  thymus or thoracic  duct cells; 0  O, 
neonatally thymectomized mice given SRBC only;  •  •,  neonatally thymectomized 
mice given 10 million Fl thymus cells and SRBC; •  •, neonatally thymectomized  mice 
given I0 million Ft thoracic duct cells and SRBC. The magnitude  of twice the standard errors 
is shown by the vertical bars. The number of mice per point was 2-8 with an average of 5. 
SRBC and F1 cells.  It can be seen that the increased response produced as a 
result of these inocula is statistically significant. Furthermore, for a given num- 
ber of cells transferred, F1 thymus cells were as effective as C57BL or F1 thoracic 
duct cells. A comparison of the results in Tables I and III shows that syngeneic 
cells  produced the  same effect as  allogeneic or semiallogeneic cells  with  the 
exception of C57BL thymus cells which were less effective. j.  ~.  A.  P.  MILLER  AND  G.  ~'.  MI"fCHELL  809 
Transfer  of Other Cells, Irradiated  Cells,  and Extracts.~Various  cellular and 
noncellular  inocula  were  tested for their  capacity  to  augment  the  immune 
response of neonatally thymectomized mice to SRBC.  Thymus and thoracic 
duct cells were irradiated in vitro in the cold with 1000 rads and injected into 
TABLE  III 
PFC Produced in the Spleens of N¢ona4ally Thymectomizod CBA Mice after InjecHon of 
SRBC and C57BL or (CBA  X  C57BL)F~ Thymus or Thoracic Duct Cells 
Average PFC per spleen  Cells inoculated  No. of mice  at 4-5 days (-4-sz)  P  values* 
SRBC 
10  X  10  e  FI  thymus cells  4-  SRBC 
10  X  10  e F~ thoracic  duct cells-}- 
SRBC 
SO  X  10  s  C57BL  thymus  cells+ 
SRBC 
10X  106  C57BL  thoracic duct 
cells +  SRBC 
16 
10 
12 
11 
10 
2,356-4-537 
22,380-4-6,285 
24,537+5,519 
17,448~3,901 
30,120~7,791 
<0.01 
<0.01 
<0.01 
<0.01 
* P values are compared with the average of the group of mice receiving SRBC only. 
TABLE  IV 
PFC Produced in the Spleens  of Neonatally  Thymectorai~d  CBA Mice after Various lnocula 
Inoculum 
SRBC 
50  X  I0  ~  irradiated  CBA thymus cells  +  SRBC 
I0  X  I06  irradiated  CBA thoracic  duct ceils  -{-  SRBC 
10  X  10  e  irradiated  (CBA X  C57BL)FI  thoracic 
ceils  -f  SRBC 
Thymus extract  -{-  SRBC 
50  X  10  e  yeast  cells  -{-  SRBC 
50  X  10  e  bone  marrow cells  -{-  SRBC 
duct 
No. of  Average PFC per spleen 
mice  at 4-5 days (± n) 
7 
4 
5 
6 
6 
6 
11 
1840 ::t: 702* 
1160 -4- 615 
3776 -',-  979 
4344-1-2540 
1802-4-1155 
2270-4-450 
3814+2189 
* This value does not differ significantly  from the average value of all other groups. 
neonatally thymectomized CBA mice with SRBC. As seen in Table IV, irra- 
diation  abolished the capacity of these cells to elevate the 4--5 day PFC  re- 
sponse. A  cell-free saline extract of thymus was injected intraperitoneally into 
neonatally  thymectomized mice  at  the  time  of  intravenous  challenge  with 
SRBC. Each mouse received the equivalent of one thymus lobe (approximately 
100  million  cells)  but  its  response  was  not  elevated.  50  million  yeast  cells, 
injected together with SRBC, were also ineffective. 50 million syngeneic bone 
marrow cells caused  a  slight but insignificant  elevation.  The large  standard 810  CELL  TO  CELL  INTERACTION  IN  IMMUNE  RESPONSE.  I 
error of the mean of this group of 11 mice was due to the response of one mouse 
which had no detectable thymus remnant,  but which produced 25,050 PFC, 
this value exceeding all others in the group by at least 18,600. 
The results obtained with irradiated cells and with thymus extracts suggest 
that  the reconstitutive capacity of normal thymus and  thoracic duct cells is 
dependent upon intact cells capable of division. Since bone marrow and yeast 
cells were ineffective, it is unlikely that the immunological capacity of thymecto- 
mized mice can be nonspecifically improved simply by the injection of large 
numbers of cells of any type. 
TABLE  V 
PFC from Spleens  of Normal  Immunized Mice Remaining  after Incubation  with Isoantlsera 
Spleen cell donor 
CBA 
CBA 
CBA 
C57BL 
C57BL 
(CBA X  C57BL)F1 
(CBA X  C57BL)F, 
!No. of PFC per aliquotwri~:  iaing after incubation 
Normal 
mouse  ~mti-C57BL  serum 
serllm 
310 
118 
662 
317 
442 
2481 
815 
Anti-CBA serum 
5o (84%)* 
17 (86%) 
68 (90%) 
360 (0%) 
367 (17%) 
16 (99%) 
31 (96%) 
4o7 (0%) 
131 (o%) 
550 (17%) 
17 (95%) 
74 (83%) 
41 (98%) 
44 (95%) 
* Number in brackets refers to per cent reduction. 
Identity  of the Hemolysin Plaque-Forming Cells.--Since  aUogeneic or semi- 
allogeneic thymus or thoracic duct cells elevated the PFC response of thymec- 
tomized CBA mice, anti-H2 isoantisera can be used to identify the cells pro- 
ducing 19S hemolysins. If the PFC were the direct descendants of C57BL or Fx 
ceils, treatment with anti-C57BL serum would be expected to reduce the num- 
ber  of  plaques  appearing  in  agar  containing  SRBC.  The  specificity of  the 
isoantisera and their effectiveness in inhibiting plaques are shown in Table V. 
Aliquots of spleen cells from normal CBA,  C57BL, and  (CBA  X  C57BL)FI 
mice, challenged 4 days before with SRBC, were incubated with normal CBA 
serum, normal C57BL serum, anti-CBA serum, or anti-C57BL serum, in the 
presence of complement. The reduction following specific or nonspecific isoanti- 
serum treatment is expressed as a percentage of the number of PFC following 
incubation with normal mouse serum.  Incubation in  the presence of normal 
CBA and normal C57BL serum was associated with an average reduction, in the 
original number of PFC, of 29 %  (22 determinations). Presumably these losses 
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period and subsequent washing and plating procedures. It can be seen in Table 
V, that anti-CBA serum reduced the number of CBA PFC by 84-90 %, that 
anti-CS7BL serum reduced the number of C57BL PFC by 83-95 %, and that 
both antisera reduced the number of FI PFC by 95-99 %. Incubation of CBA 
PFC with anti-C57BL serum or of C57BL PFC with anti-CBA serum was 
associated with a loss ranging from 0-17 %. The capacity of specific isoantisera 
to affect PFC in a mixed population of CBA and C57BL spleen cells was next 
TABLE VI 
PFC from Spleens of Recons~itute,  d Neonalally Thymectomized CBA  Mice Remaining after 
Incubation with Isoantisera 
Cells used for reconstitution 
C57BL thymus cells 
C57BL thymus cells 
C57BL thoracic duct cells 
C57BL thoracic duct cells 
C57BL spleen cells 
(CBA X C57BL)F1 thymus cells 
(CBA X C57BL)F1 thoracic duct cells 
(CBA X C57BL)F1 thoracic duct cells 
(CBA X C57BL)FI thoracic duct cells 
(CBA X C57BL)FI thoracic duct cells 
(CBA X C57BL)F~ thoracic duct cells 
No. 
splee~ 
in po~ 
5 
3 
4 
6 
2 
3 
6 
4 
2:L 
3~ 
No. of PFC per aliquot remaining after incubation 
with: 
Normal  Anti-CBA 
mouse 
senIH1  seru£a 
46O 
363 
1612 
142 
1536 
609 
130 
744 
1174 
90 
817 
37 
36 
60 
20 
126 
20 
7 
84 
29 
0 
7 
Anti-C57BL serum 
(92%)*  407 (12%) 
(9o'70)  334 (8%) 
(96%)  1930 (0%) 
(85%)  140 (1%) 
(92%)  1512 (2%) 
(97%)  571 (6%) 
(95%)  108 (17%) 
(89%)  958 (0%) 
(98%)  1454 (0%) 
(108%)  80  (11%) 
(99%)  796 (3%) 
* Number in brackets  refers to per cent reduction. 
Spleens assayed 7 days after thoracic duct cells were inoculated;  all others were assayed 
4-5 days after cell inoculation. 
tested. A total of 551 PFC consisting  of 221 C57BL PFC and 330 CBA PFC 
were incubated with  anti-CBA  or anti-C57BL sera. The number remaining 
after anti-CBA serum was 205 and after anti-C57BL serum was 285. Thus these 
antisera caused a reduction commensurate with the known content of PFC of 
one or other type in the mixture. 
The results of 11 experiments involving 41 reconstituted mice are shown in 
Table VI.  Spleens  from thymectomized CBA mice reconstituted with either 
C57BL thymus or thoracic duct cells were taken 4-5 days after challenge with 
SRBC and aliquots of the cell suspensions  were incubated with ant~rC57BL 
serum. The reduction in the number of PFC was 0-12%. On the other hand, 
incubation with  anti-CBA serum reduced the number of PFC by 86-96%. 
When F1 thymus or thoracic duct cells were used to reconstitute, anti-CBA 812  CELL  TO  CELL  INTERACTION  IN  IMMUNE  RESPONSE,  I 
serum (which is directed against both donor and host cell types) reduced the 
number of PFC by 89--97 %. On the other hand, anti-C57BL serum (which is 
directed only against the donor cell type) caused a reduction in PFC of 0-17 %. 
Since the peak response of thymectomized mice reconstituted with FI thoracic 
duct cells occurs 7 days after challenge (Fig. 3), spleen cells were taken at that 
time and incubated with isoantisera. The results show that anti-CBA serum 
reduced the number of PFC by 98-100%  and aati-C57BL serum by 0--11%. 
When 50 million C57BL spleen cells were injected into thymectomized CBA 
mice the PFC response was increased to 23,875. Anti-CBA serum reduced the 
number of PFC  by 92%  and  anti-C57BL  serum  by only 2%.  These  data 
TABLE VII 
PFC Produced in Response to SRBC and ltRBC in tire Spleens of CBA Mice* Treated 23-26 
Days before uqtk SRBC and Cyclophos  ~haraide 
Treatment 
SRBC and cyclophosphamide 
Cyclophosphamide only 
Erythrocytes used 
for challenge 
and assay 
SRBC 
HRBC 
SRBC 
HRBC 
No. of mice 
9 
3 
12 
3 
Average PFC per spleen  at 
4-5 days (~sz) 
2,766 4-  585~ 
47,833 4- 4,110§ 
144,650 4- 16,562~ 
72,600 4- 14,440§ 
* Some of these mice were used as donors  of thoracic duct lymphocytes  which were trans- 
ferred to neonatally thymectomized  mice (Table VIII). 
P  < 0.001. 
§ Not significant. 
indicate that the majority, if not all of the PFC arising in reconstituted thymec- 
tomized mice were derived not from the inoculated cells but from the thymec- 
tomized host. 
Transfer of Thoracic Duct Cells from Mice Tolerant of Sheep Erythrocytes.-- 
Since  thoracic  duct  lymphocytes could  restore  the  capacity  of  neonatally 
thymectomized mice  to  respond  to SRBC,  it  was  of interest  to  determine 
whether this might also be achieved by thoracic duct cells from donors specifi- 
cally tolerant of SRBC. It is evident from the results shown in Table VII that 
the  lymphocyte donors  used  were  specifically tolerant.  Those  treated  with 
SRBC  and  cyclophosphamide 3--4 wk  before challenge,  produced  in  their 
spleens only 2766  PFC in response  to  SRBC in contrast to 47,833  PFC in 
response to HRBC. The cyclophosphamide-treated controls gave, in response 
to SRBC,  144,650  PFC per spleen,  which exceeds what is generally seen in 
normal 6- to 8-wk-old CBA mice used in this laboratory (3).  10 million thoracic 
duct cells from tolerant donors or from cyclophosphamide-treated controls were 
injected intravenously together  with  SRBC  into neonatally thymectomized ~'.  F.  A.  P.  MILLER  AND  G.  F.  MITCHELL  813 
CBA  mice  and  the PFC  response  determined 4-5  days later.  The results, 
shown in Table VIII, indicate that the response was much lower in recipients of 
cells from tolerant donors than from cyclophosphamide-treated controls.  The 
response in the latter was higher than that in recipients of the same number of 
normal thoracic duct cells obtained from 6- to 8-wk-old donor mice (Table I). 
This may be a reflection of the age of the donors or of factors associated with the 
recovery from the effects of cyclophosphamide. From a comparison of the data 
given in Table I  and Table VIII it can be seen  that the PFC produced in 
response  to SRBC in the spleens of neonatally thymectomized CBA was in- 
creased slightly by an injection of "tolerant" cells. The fact that tolerance was 
not complete in the donors (Table VII) may account for this. 
TABLE  VIII 
PFC Produced in the Spleens of Neonatally Thymectomlzed CBA Mice after Injection of SRBC 
and Syngeneic Thoracic Duct Cells ~rom  Mice Specifically Tolerant of SRBC 
Cells Inoculated 
~RBC -t- 10  7 thoracic duct cells from cyclo- 
phosphamide-treated donors 
~RBC -t- l0  T  thoracic duct cells  from toler- 
ant  donors (treated with SRBC and 
cyclophosphamide) 
No. of 
mice 
Average PFC per sl~leen at 
4~ days (±sE) 
41,500.4-13,436 
7,331-4-2,276 
P value 
<0.05 
DISCUSSION 
In many experimental  situations, the immunological performance of thymus 
cells was found to be far inferior to that of ceils from spleen or lymph nodes (1). 
Thus, for instance, when relatively small numbers of thymus cells (up to 20 
million) were injected into thymectomlv~A mice soon after birth, the response to 
certain antigens given in later life was not improved and wasting disease was not 
prevented. By contrast, 5-20 million spleen or lymph node cells were effective 
(21, 22). Huge numbers of thymus cells (100-300 million) could however, reverse 
the effects of neonatal thymectomy (23,24) although no comparison was made 
between spleen and lymph node ceils on the one hand, and thymus cells on the 
other, with respect to the minimal dose required to achieve an effect. The results 
reported here indicate that thymus ceils were as good as thoracic duct ceils in 
enabling  neonatally thymectomized mice  to  respond  to  sheep  erythrocytes 
when the antigen was given together with the ceils, but 50 million thymus ceUs 
were inferior  to 10 million thoracic duct ceils in preventing wasting disease. 
In  previous  studies,  sheep  erythrocytes were  injected  some  weeks  after 
thymus cells (25). The failure to achieve an effect in these experiments may be 
ascribed to the possibility that thymus ceils were no longer available in adequate 814  CELL  TO  CELL  INTERACTION  IN  r~%fLTNE  RESPONSE.  I 
numbers at the time of antigenic challenge owing to some previous  immuno- 
logical commitment or to a limited lifespan in the absence of specific antigenic 
stimulation. These possibilities  may also be invoked to explain  the reduced 
effectiveness of thymus cells in preventing wasting disease. In experiments  in 
which  bovine  serum  albumin was  injected into  the foot-pad of neonatally 
thymectomized rats at the same time as an intravenous injection of lympho- 
cytes, cells from lymph nodes but not from thymus restored the capacity to 
express delayed hypersensitivity (26). There seems to be some discrepancy be- 
tween these results and those presented here as well as those reported by Taylor 
(27). This might, however,  reflect differences in the capacity of thymus and 
lymph node cells to reach  the sites in which the effector cells of the immune 
response are being generated.  The reaction to a foot-pad injection of bovine 
serum albumin is probably mediated in the regional lymph nodes in contrast to 
the antibody response to sheep erythrocytes which occurs in the spleen (28). 
Intravenously injected thymus cells recirculate  to  a  far lesser  extent than 
thoracic duct cells (and presumably lymph node cells) (29), and migrate in 
larger numbers to the spleen than to the lymph nodes (30, 31). This differentia] 
homing of thymus cells may be further exaggerated in the neonata]ly thymec- 
tomized mice used in this study, as a result of their greatly enlarged spleens. 
It is highly probable  that the effective cells in the thymus cell suspensions 
used in our experiments  were lymphocytes, since these cells predominate and 
since smears of the suspensions revealed only  few epithelial cells or macrophages. 
An inoculum of 50 million  thymus cells is probably contaminated by some 
blood-borne  lymphocytes. It  is  unlikely that  this  contaminant population 
accounts for the effects observed even if we assume that the proportion of blood 
lymphocytes in the cell suspension used was as much as 10 %. Thus 1.5 million 
thoracic duct cells produced by no means as  great an effect  as  10  million 
thymus cells. 
The kinetics of  the PFC  response  in  thymectomized mice  injected with 
thymus or thoracic duct cells exhibited some differences. In the case of neona- 
tally thymectomized mice  given  thymus cells the  time-response  curve  was 
similar to that of sham-operated controls. In the case of recipients of thoracic 
duct cells the number of PFC produced remained elevated at a time when it 
was falling in controls  or in thymus-injected mice. This was evident whether 
syngeneic or FI cells were used. It is not known to what extent these features 
reflect differences in the population of cells inoculated.  The prolonged response 
may be associated with the capacity of thoracic duct lymphocytes to recirculate 
and to be recruited continually into the antigenically stimulated spleen  (32) 
thus allowing further production of PFC. Thymus cells, on the other hand, may 
not recirculate  to the same extent (29). Alternatively, some delay in feedback 
inhibition may have occurred in recipients of thoracic duct cells. 
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different H2 antigenic complexes has been documented in the experiments in 
which hemolysin-forming cells from CBA and C57BL donors were mixed in 
known proportions and exposed to either anti-CBA or anti-CS?BL serum. The 
reduction in number of PFC obtained in either case could be ascribed solely to 
an effect of the specific  isoantiserum used.  Furthermore, hemolysin-forming 
ceils  from F1 mice were reduced  significantly with either anti-CBA or anti- 
C57BL serum indicating that both parental H2 antigens were expressed on the 
heterozygous cells as has been previously reported (33). From the data obtained 
when  spleens  from  normal  immunized  mice  were  incubated  with  specific 
isoantisera, it is  evident that the efficiency of these sera is such that a  loss 
ranging from 80-100%  can be achieved. These considerations enable one to 
conclude that at least 80 % of the PFC in spleens of neonatally thymectomized 
CBA mice reconstituted with F1 cells were derived from the host. It is unlikely 
that, in the environment of a CBA host, PFC of F1 origin would express  only 
one of the parental H2 complexes. Complete loss of an entire H2 complex has 
been recorded in heterozygous tumor cells  but only after exposure,  through 
serial  transplantation,  to  considerable  immunological pressure  against  the 
complex (34). Furthermore, as will be evident in the second paper in this series 
(35), Fl-type PFC were detected in the environment of an irradiated CBA host. 
In the case of CBA mice receiving C57BL cells,  the possibility of antigenic 
exclusion cannot be entertained as complete loss of all H2 complexes has never 
been achieved, even in tumor cells (34). 
It might be suggested that FI or C57BL cells were either rejected or inhibited 
from differentiating in neonataily thymectomized CBA mice, thus accounting 
for the failure to detect PFC of donor origin. If this is the case, then one must 
surmise that the restoration of responsiveness to SRBC is the result of a con- 
comitant host  versus  graft reaction which nonspecifically boosted the  host's 
response. This is most unlikely since syngeneic cells were restorative and since 
irradiated F1 cells were  ineffective. Furthermore,  rejection of  F1 or  C57BL 
tissues does not occur following neonatal thymectomy. Thus all the mice in a 
group of 12 neonatally thymectomized  mice used in the present experiments and 
grafted with C57BL skin at I or 3 wk of age died of wasting disease with their 
grafts intact. 
No donor-type PFC  were detected in  the spleens of thymectomized mice 
reconstituted with C57BL spleen cells.  This suggests that PFC precursors of 
host origin are stimulated to differentiate in preference to precursor cells which 
must have been present in the inoculum of normal spleen cells. Presumably the 
host precursor cells are readily available in strategic sites within the recipient's 
spleen and are already in a state when their differentiation to PFC can readily 
be induced. Hence the fact that no donor-type PFC were detected in thymec- 
tomized mice reconstituted with either thymus or thoracic duct ceils does not 
preclude the possibility that PFC precursors existed in these cell populations. It 816  CELL  TO  CELL  INTEKACTION  IN  IMMUNE  RESPONSE.  I 
is probable that, in order to detect them, a recipient lacking precursors, such as a 
heavily irradiated host, has to be used. This will be the subject of the investiga- 
tions in the next paper (35). 
The above considerations lead us to the conclusion that the immunologically 
deficient  neonatally thymectomized host provides  PFC precursors,  but that 
these can differentiate to PFC in response  to SRBC only in the presence  of 
thymus or thoracic duct cells. The questions  may now be asked:  from what 
cell type does the PFC precursor  arise and what is the role of the thymus or 
thoracic duct cell in this reaction? As will be seen in the next paper (35), a cell 
type in bone marrow, presumably after undergoing some differentiation, pro- 
vides the precursors of the PFC. This is supported by previous work in which it 
was shown that the bone marrow of neonatally thymectomized mice was as 
effective as that of normal mice in restoring immunological responsiveness to 
nonthymectomized, heavily irradiated mice (36). 
The role of thymus or thoracic duct lymphocytes in reconstituting thymec- 
tomized  mice could be to provide  nonspecific factors which enhance the re- 
activity  of their hosts. It has been shown, for instance, that various cellular and 
noncellular  inocula,  including  yeast, could  elevate the  immune response  of 
irradiated rabbits (37, 38) and that oligodeoxyribonucleotides were capable of 
stimulating the early rate of increase of PFC in spleens of mice challenged with 
antigens such as SRBC (39). In the present study, however, attempts to restore 
thymectomized mice  by using irradiated  syngeneic  or  semiallogeneic  cells, 
bone marrow cells, yeast, or thymus extracts have failed. This suggests that the 
activity of intact thymus or thoracic duct lymphocytes may be dependent on 
cells capable of division (presumably in response to antigenic stimulation) and 
not on the provision of nonspecific trephocytic, adjuvant, or hormonal factors. 
A discussion of the possible role of a humoral thymus factor presumed to be a 
product of the e[~l~elial cells (21, 40), is beyond the scope of the present studies 
in which thymus ly~pkocytes were used to reconstitute mice. 
Perhaps thymus or thoracic duct ceils act as precursors  of specialized  ceils 
which process  antigen and focus a  "super-antigen" to the sites where  PFC 
precursors  reside,  or perhaps  they play a more  specific role in the  response 
to SRBC. It has been shown that both tolerance and immunological memory are 
functions of the lymphocyte population of thoracic duct lymph (41, 42). Pre- 
liminary results  obtained here indicate that thoracic duct ceils from donors 
immunologically tolerant  of  SRBC  had  a  reduced  restorative  capacity in 
neonatally thymectomized recipients of SRBC. The host, in this situation, was 
capable of providing PFC precursors, so that is is unlikely  that specific tolerance 
is a  property carried exclusively by the PFC precursor  cell line. It is more 
plausible  to suggest  that the  specific reactivity, which  is  abolished  by the 
induction of immunological tolerance,  is linked to the cell types, in thymus or 
thoracic duct lymph, which are essential to induce PFC precursors to differenti- ~'. ~'. A. P.  MILLER AND G. 1¢. MITCHELL  817 
ate in response to SRBC. These cell types might then play a highly specific role 
in the hnmune response, viz. antigen recognition and the carriage of long-term 
immunological memory, and would thus deserve the name "antigen-reactive 
cells." H  this is the case,  then the question must be raised as to which cell 
type--the  antigen-reactive  ceil  or  the  antibody-forming  cell  precursor--is 
involved in the genetic control of antibody synthesis. Experiments employing 
allotype markers may help to resolve this question and will be the subject of a 
subsequent paper in the present series. 9 
SUMM  kR¥ 
An injection of viable thymus or thoracic duct lymphocytes was absolutely 
essential to enable a normal or near-normal 19S hemolysin-forming  cell response 
in the spleens of neonatally thymectomized mice challenged with sheep eryth- 
rocytes.  Syngeneic thymus lymphocytes were  as  effective as  thoracic  duct 
lymphocytes in this system and allogeneic or semiallogeneic cells could also 
reconstitute their hosts. No significant elevation of the response was achieved by 
giving either  bone  marrow  cells,  irradiated  thymus or  thoracic  duct  cells, 
thymus extracts or yeast. Spleen cells from reconstituted mice were exposed to 
anti-H2 sera directed against either the donor of the thymus or thoracic duct 
cells, or against the neonatally thymectomized host. Only isoantisera directed 
against the host could significantly reduce the number of hemolysin-forming 
cells present in the spleen cell suspensions. It is concluded that these antibody- 
forming cells  are derived, not from the inoculated thymus or thoracic duct 
lymphocytes, but from the host. Thoracic duct cells from donors specifically 
immunologically tolerant  of  sheep  erythrocytes  had  a  markedly  reduced 
restorative capacity in neonatally thymectomized recipients challenged with 
sheep erythrocytes. These results have suggested that there are cell types, in 
thymus or thoracic duct lymph, with capacities to react specifically with antigen 
and  to  induce  the  differentiation, to  antibody-forming ceils,  of hemolysin- 
forming cell precursors derived from a separate cell line present in the neonataUy 
thymectomized hosts. 
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